awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26749180-AB94A0C6-A44B-424B-9DEF-4234284ACCBB
Q26749180-AB94A0C6-A44B-424B-9DEF-4234284ACCBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26749180-AB94A0C6-A44B-424B-9DEF-4234284ACCBB
Treatment of relapsed and refractory multiple myeloma
P2860
Q26749180-AB94A0C6-A44B-424B-9DEF-4234284ACCBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26749180-AB94A0C6-A44B-424B-9DEF-4234284ACCBB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7007edba00ceb1313191607bb5c871b33cbba3e7
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.